Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay targeting katG codon 315 variation

被引:78
作者
Mokrousov, I
Otten, T
Filipenko, M
Vyazovaya, A
Chrapov, E
Limeschenko, E
Steklova, L
Vyshnevskiy, B
Narvskaya, O
机构
[1] St Petersburg Pasteur Inst, Mol Microbiol Lab, St Petersburg 197101, Russia
[2] Res Inst Phthisiopulmonol, Lab Microbiol TB, St Petersburg 193063, Russia
[3] Russian Acad Sci, Inst Bioorgan Chem, Siberian Div, Novosibirsk 630090, Russia
[4] City Anti TB Dispensary, St Petersburg 196158, Russia
关键词
D O I
10.1128/JCM.40.7.2509-2512.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We describe a simple multiplex allele-specific (MAS)-PCR assay to detect mutations in the second base of the katG gene codon 315, including AGC-->ACC and ACA (Ser-->Thr) substitutions that confer resistance to isoniazid (INH) in Mycobacterium tuberculosis clinical isolates. The 315 ACC allele is found in the majority of Inh(r) strains worldwide, especially in areas with a high incidence of tuberculosis. The 315 ACA allele is characteristic of the New York City multidrug-resistant (MDR) strain W and its progenies in the United States. The mutations in katG315 are revealed depending on the presence or absence of an indicative fragment amplified from the wild-type allele of this codon. Initially optimized on the purified DNA samples, the assay was then tested on crude cell lysates and auramine-stained sputum slide preparations with the same reproducibility and interpretability of profiles generated by agarose gel electrophoresis. The MAS-PCR assay can be used for the detection of resistance to INH in clinical laboratories in regions with a high prevalence of MDR M. tuberculosis strains.
引用
收藏
页码:2509 / 2512
页数:4
相关论文
共 26 条
[1]   Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG [J].
Abate G. ;
Hoffner S.E. ;
Miörner H. .
European Journal of Clinical Microbiology and Infectious Diseases, 2001, 20 (5) :329-333
[2]   Differentiation of bacterial 16S rRNA genes and intergenic regions and Mycobacterium tuberculosis katG genes by structure-specific endonuclease cleavage [J].
Brow, MAD ;
Oldenburg, MC ;
Lyamichev, V ;
Heisler, LM ;
Lyamicheva, N ;
Hall, JG ;
Eagan, NJ ;
Olive, DM ;
Smith, LM ;
Fors, L ;
Dahlberg, JE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (12) :3129-3137
[3]  
Dobner P, 1997, INT J TUBERC LUNG D, V1, P365
[4]  
Dragon Elizabeth A., 1993, P160
[5]  
Escalante P., 1998, Tubercle and Lung Disease, V79, P111, DOI 10.1054/tuld.1998.0013
[6]   Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997) [J].
Fang, Z ;
Doig, C ;
Rayner, A ;
Kenna, DT ;
Watt, B ;
Forbes, KJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) :998-1003
[7]   Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa [J].
Haas, WH ;
Schilke, K ;
Brand, J ;
Amthor, B ;
Weyer, K ;
Fourie, PB ;
Bretzel, G ;
StichtGroh, V ;
Bremer, HJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1601-1603
[8]   Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa [J].
Kiepiela, P ;
Bishop, KS ;
Smith, AN ;
Roux, L ;
York, DF .
TUBERCLE AND LUNG DISEASE, 2000, 80 (01) :47-56
[9]   Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore [J].
Lee, ASG ;
Lim, IHK ;
Tang, LLH ;
Telenti, A ;
Wong, SY .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :2087-2089
[10]   katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients [J].
Marttila, HJ ;
Soini, H ;
Huovinen, P ;
Viljanen, MK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) :2187-2189